Accuracy of self-reported medicines use compared to pharmaceutical claims data amongst a national sample of older Australian women

HTML  XML Download Download as PDF (Size: 106KB)  PP. 25-32  
DOI: 10.4236/ojepi.2013.31005    3,376 Downloads   6,367 Views  Citations

ABSTRACT

This study assessed agreement between two measures of medicine use, self-report by mail and pharmaceutical claims data, for a national sample (N = 4687) of older women aged 79 to84 in2005, from the Australian Longitudinal Study on Women’s Health. Medicines used for common chronic diseases in older people were selected, with pharmaceutical claims data retrieval periods of three and six months. For six month retrieval, Kappa’s ranged between 0.44 (nervous system medicines) and 0.94 (glucose lowering medicines). For three month retrieval, aspirin (Kappa: 0.35) and folic acid (Kappa = 0.48) had lowest agreement. Women were least able to accurately report use of nervous system medicines (sensitivity < 50%), and most accurately report glucose lowering medicines use (sensitivity > 80%). Specificity was consistently high across all classes, suggesting women could accurately report using a medicine. Pharmaceutical claims data can assist evaluation of judicious medicines use, changes to availability and uptake of medicines, and track medicine expenditure for chronic conditions. Over-the-counter medicines, medicines not covered by pharmaceutical subsidies and those used on an as needed basis may be best measured by self-report, as use may be underestimated using pharmaceutical claims data.

Share and Cite:

Dolja-Gore, X. , Pit, S. , Parkinson, L. , Young, A. and Byles, J. (2013) Accuracy of self-reported medicines use compared to pharmaceutical claims data amongst a national sample of older Australian women. Open Journal of Epidemiology, 3, 25-32. doi: 10.4236/ojepi.2013.31005.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.